This study was to investigate the hepatic pathophysiology and biochemical changes during antituberclosis therapy. Among the intake 200 patients: 60 were on therapy, another 60 were not on therapy, while 80 were non tuberculosis patient. A comparative decrease in the level of total protein and albumin in tuberculosis patients were recorded while increase in Asparate Aminotransfarace (AST), Alanine Aminotransferace (ALT), and Alkaline Phosphatase (ALP) were observed in comparison with the control. On treatment with antituberclosis therapy, the hepatic involvements are transient.
Keywords
Biochemical Indices, Hepatic Pathophysiology, Antituberculosis Therapy
User
Information